Chris Nishioka, PhD | Field Applications Scientist, Molecular Devices
Tim Baranowski, PhD | Field Applications Scientist, Molecular Devices
Bas Trietsch, PhD | Chief Technology Officer, MIMETAS
Shannon Mumenthaler, PhD | Professor of Medicine, USC
There has been a recent shift toward using 3D cell models in drug discovery and disease modeling, as numerous studies show they better mimic the in vivo environment and provide more physiologically-relevant data than 2D models.
In this roundtable discussion, our panel of experts discuss the benefits and inherent challenges of making the transition from traditional 2D high-content assays to more complex 3D biology.